Cobenfy: The First New Schizophrenia Drug in Decades
Key TakeawaysThe FDA has approved Cobenfy, the first new schizophrenia treatment in over 30 years.Cobenfy helps reduce both positive and negative schizophrenia symptoms, with side effects compared to current medications.Clinical trials for Cobenfy showed no significant weight gain or treatment discontinuation, but long-term effectiveness remains uncertain due to short study durations.The Food and Drug Administration (FDA) last week approved Bristol Myers Squibb’s antipsychotic drug Cobenfy (xanomeline and trospium chloride), the firstschizophreniatreatment with an entirely new mechanism of action in over 70 years....